Top DoD pharmaceutical preparation manufacturing contractors (NAICS 325412)
- Latest 12 months
- $52.9M
- Net obligations · Down $30.1M vs. $83.0M preceding
- Prime contractors
- 72
- With positive obligations in the latest 12 months
Research the DoD federal contracting market for pharmaceutical preparation manufacturing under NAICS 325412. Compare top federal contractors and market share, reported contract obligations and spending trends, funding-office attribution, recent award activity, contract types, competition, and procurement methods, and observed contract vehicle usage.
Contract obligation trends for Pharmaceutical Preparation Manufacturing at the Department of Defense
Federal records show $26.3B in net obligations across 80,885 awards in Pharmaceutical Preparation Manufacturing at the Department of Defense from Oct 1, 2021 through Oct 23, 2026. This market accounts for 1.2% of $2.3T in agency-wide net prime contract obligations over the period shown. Latest 12-month net obligations decreased 36.2% from $83.0M to $52.9M. 6 prime contractors accounted for at least 80% of positive obligations in that latest period.
Fiscal-year activity
FY27 is year-to-date through Oct 23, 2026; earlier years show complete fiscal-year totals.
View fiscal-year data table
| Fiscal year | Net obligations | Contract actions | Coverage |
|---|---|---|---|
| FY2022 | $24.0B | 18,496 | Complete |
| FY2023 | $2.0B | 16,837 | Complete |
| FY2024 | $116.4M | 17,387 | Complete |
| FY2025 | $89.0M | 23,694 | Complete |
| FY2026 | $54.5M | 9,254 | Complete |
Market at a glance
All reported prime contract awards- All-period net obligations
- $26.3B
- 80,885 awards · 219 prime contractors
- Latest 12-month movement
- −36.2%
- $52.9M vs. $83.0M
- Leading eight prime share
- 84.5%
- Share held by the eight leading prime contractors in the latest 12 months
View agency share, denominators, and set-aside reporting
- Agency context
- 1.2% of $2.3T in agency-wide net obligations.
- Set-aside share when reported
- 0.9% of 11,822 awards with reported set-aside status.
- Set-aside reporting
- 110 set aside · 11,712 no set-aside · 69,063 not reported
What changed in the last 12 months?
Oct 24, 2025–Oct 23, 2026, compared with Oct 24, 2024–Oct 23, 2025.
Competitive shifts
TEVA PHARMACEUTICALS USA, INC. had the largest decline in reported obligations
AMERICAN REGENT INC fell the most in the contractor rankings
ADVANCED ACCELERATOR APPLICATIONS USA INC had no reported activity in the latest 12 months
Buyer demand
Reported obligations through DLA TROOP SUPPORT decreased
Reported obligations through AMC BAMC FSH - MM increased
How these findings are calculated
Findings are selected from matched-period changes in obligations, share, rank, funding offices, concentration, reported set-asides, material award actions, and agency-peer outliers. Related signals are combined, and only material evidence-backed changes are shown. Review the full methodology.
Federal contract obligations by funding office
See how positive obligations were attributed across funding offices in the 12 months ending Oct 23, 2026.
43.2% of positive obligations were attributed to DLA TROOP SUPPORT (SPE2DP). That represents $22.8M, down $24.2M from the preceding 12 months.
Latest 12-month share of positive obligations; the gray segment represents all other reported offices.
- DLA TROOP SUPPORT (SPE2DP)43.2% · $22.8M · down $24.2M
- DLA TROOP SUPPORT (SPE2D6)21.4% · $11.3M · down $188K
- AMC BAMC FSH - MM11.1% · $5.9M · up $2.9M
- DIRECTOR, WRNMMC4.0% · $2.1M · down $686K
- AMC BEAUMONT BLISS - MM4.0% · $2.1M · up $1.1M
- All other reported offices16.3% of positive obligations
View reported office rankings, comparisons, and evidence
USAspending assigns each award to a funding office. That office may differ from the requiring activity, program office, contracting office, individual buyer, or actual customer.
Reported funding office
DLA TROOP SUPPORT (SPE2DP)
#1Rank unchangedLatest 12 months
$22.8M
43.2% of positive obligations
Versus preceding 12 months
−$24.2M
29 active prime contractors · 2,241 awards
View office comparison and evidence
Reported obligations decreased 51.5% from $47.1M to $22.8M. The office’s share of positive obligations moved from 56.3% to 43.2%, a change of −13.2 percentage points.
The latest period contains 2,246 actions across 2,241 awards and 7 newly active prime contractors. The preceding period contained 38 active prime contractors and 16,219 awards.
Leading award-level changes
- TEVA PHARMACEUTICALS USA, INC. · PIID SPE2DP25F2789−$5.3M: $5.3M → $0
- TEVA PHARMACEUTICALS USA, INC. · PIID SPE2DP26F1649+$4.0M: $0 → $4.0M
Reported funding office
DLA TROOP SUPPORT (SPE2D6)
#2Rank unchangedLatest 12 months
$11.3M
21.4% of positive obligations
Versus preceding 12 months
−$188K
1 active prime contractor · 103 awards
View office comparison and evidence
Reported obligations decreased 1.6% from $11.5M to $11.3M. The office’s share of positive obligations moved from 13.8% to 21.4%, a change of +7.6 percentage points.
The latest period contains 103 actions across 103 awards. The preceding period contained 1 active prime contractor and 198 awards.
Reported funding office
AMC BAMC FSH - MM
#3Up 2 from #5Latest 12 months
$5.9M
11.1% of positive obligations
Versus preceding 12 months
+$2.9M
14 active prime contractors · 19 awards
View office comparison and evidence
Reported obligations increased 97.5% from $3.0M to $5.9M. The office’s share of positive obligations moved from 3.5% to 11.1%, a change of +7.5 percentage points.
The latest period contains 37 actions across 19 awards and 2 newly active prime contractors. The preceding period contained 16 active prime contractors and 30 awards.
Leading award-level changes
- NOVARTIS PHARMACEUTICALS CORPORATION · PIID W81K0025FA195+$3.2M: $0 → $3.2M
- CARDINAL HEALTH 414, LLC · PIID W81K0024F0127−$1.0M: $1.0M → $0
Reported funding office
DIRECTOR, WRNMMC
#4Up 2 from #6Latest 12 months
$2.1M
4.0% of positive obligations
Versus preceding 12 months
−$686K
10 active prime contractors · 11 awards
View office comparison and evidence
Reported obligations decreased 24.2% from $2.8M to $2.1M. The office’s share of positive obligations moved from 3.4% to 4.0%, a change of +0.7 percentage points.
The latest period contains 12 actions across 11 awards and 2 newly active prime contractors. The preceding period contained 10 active prime contractors and 16 awards.
Reported funding office
AMC BEAUMONT BLISS - MM
#5Up 6 from #11Latest 12 months
$2.1M
4.0% of positive obligations
Versus preceding 12 months
+$1.1M
8 active prime contractors · 9 awards
View office comparison and evidence
Reported obligations increased 111.5% from $1.0M to $2.1M. The office’s share of positive obligations moved from 1.2% to 4.0%, a change of +2.8 percentage points.
The latest period contains 14 actions across 9 awards. The preceding period contained 10 active prime contractors and 14 awards.
Reported funding office
KIMBROUGH AMB CC MEADE - MM
#6Up 1 from #7Latest 12 months
$1.2M
2.2% of positive obligations
Versus preceding 12 months
−$513K
2 active prime contractors · 3 awards
View office comparison and evidence
Reported obligations decreased 30.5% from $1.7M to $1.2M. The office’s share of positive obligations moved from 2.0% to 2.2%, a change of +0.2 percentage points.
The latest period contains 4 actions across 3 awards. The preceding period contained 3 active prime contractors and 6 awards.
Reported funding office
AMC TRIPLER SHAFTER - MM
#7New to the positive-obligation rankingLatest 12 months
$1.0M
2.0% of positive obligations
Versus preceding 12 months
+$1.3M
5 active prime contractors · 7 awards
View office comparison and evidence
Reported obligations moved from $245K in net deobligations to $1.0M in net obligations. The office’s share of positive obligations moved from 0% to 2.0%, a change of +2.0 percentage points.
The latest period contains 19 actions across 7 awards and 1 newly active prime contractor. The preceding period contained 5 active prime contractors and 6 awards.
Reported funding office
DLA TROOP SUPPORT (SPE2D9)
#8Rank unchangedLatest 12 months
$925K
1.8% of positive obligations
Versus preceding 12 months
−$525K
1 active prime contractor · 4,986 awards
View office comparison and evidence
Reported obligations decreased 36.2% from $1.5M to $925K. The office’s share of positive obligations moved from 1.7% to 1.8%, a change of 0.0 percentage points.
The latest period contains 4,986 actions across 4,986 awards. The preceding period contained 1 active prime contractor and 4,635 awards.
Reported funding office
NAV MED CNT PORTSMOUTH VA - MM
#9Up 1 from #10Latest 12 months
$767K
1.4% of positive obligations
Versus preceding 12 months
−$285K
4 active prime contractors · 5 awards
View office comparison and evidence
Reported obligations decreased 27.1% from $1.1M to $767K. The office’s share of positive obligations moved from 1.3% to 1.4%, a change of +0.2 percentage points.
The latest period contains 7 actions across 5 awards. The preceding period contained 4 active prime contractors and 5 awards.
Reported funding office
AMC GORDON - PB
#10Up 7 from #17Latest 12 months
$570K
1.1% of positive obligations
Versus preceding 12 months
+$327K
3 active prime contractors · 3 awards
View office comparison and evidence
Reported obligations increased 134.8% from $243K to $570K. The office’s share of positive obligations moved from 0.29% to 1.1%, a change of +0.8 percentage points.
The latest period contains 5 actions across 3 awards. The preceding period contained 4 active prime contractors and 5 awards.
Reported funding office
NAV MED CTR SAN DIEGO CA - MM
#11Up 24 from #35Latest 12 months
$554K
1.1% of positive obligations
Versus preceding 12 months
+$510K
2 active prime contractors · 3 awards
View office comparison and evidence
Reported obligations increased 1168.2% from $44K to $554K. The office’s share of positive obligations moved from 0.050% to 1.1%, a change of +1.0 percentage points.
The latest period contains 5 actions across 3 awards and 1 newly active prime contractor. The preceding period contained 1 active prime contractor and 2 awards.
Reported funding office
DLA TROOP SUPPORT (SPE2D0)
#15Down 12 from #3Latest 12 months
$269K
0.51% of positive obligations
Versus preceding 12 months
−$3.6M
2 active prime contractors · 22 awards
View office comparison and evidence
Reported obligations decreased 93.1% from $3.9M to $269K. The office’s share of positive obligations moved from 4.7% to 0.51%, a change of −4.1 percentage points.
The latest period contains 22 actions across 22 awards. The preceding period contained 8 active prime contractors and 47 awards.
Reported funding office
AMC HOOD - PA
#18New to the positive-obligation rankingLatest 12 months
$232K
0.44% of positive obligations
Versus preceding 12 months
+$352K
2 active prime contractors · 3 awards
View office comparison and evidence
Reported obligations moved from $120K in net deobligations to $232K in net obligations. The office’s share of positive obligations moved from 0% to 0.44%, a change of +0.4 percentage points.
The latest period contains 9 actions across 3 awards. The preceding period contained 4 active prime contractors and 4 awards.
Reported funding office
FA4427 60 CONS LGC
No positive-obligation rankLatest 12 months
$0
0% of positive obligations
Versus preceding 12 months
−$720K
0 active prime contractors · 0 awards
View office comparison and evidence
Reported obligations decreased 100.0% from $720K to $0. The office’s share of positive obligations moved from 0.86% to 0%, a change of −0.9 percentage points.
The latest period contains 0 actions across 0 awards. The preceding period contained 1 active prime contractor and 1 award.
Reported funding office
W6DZ CPE CBRND FT DETRICK
No positive-obligation rankLatest 12 months
$0
0% of positive obligations
Versus preceding 12 months
−$1.2M
0 active prime contractors · 0 awards
View office comparison and evidence
Reported obligations decreased 100.0% from $1.2M to $0. The office’s share of positive obligations moved from 1.5% to 0%, a change of −1.5 percentage points.
The latest period contains 0 actions across 0 awards. The preceding period contained 1 active prime contractor and 1 award.
Reported funding office
W2DN BROOKE AMC
No positive-obligation rankLatest 12 months
$0
0% of positive obligations
Versus preceding 12 months
−$3.8M
0 active prime contractors · 0 awards
View office comparison and evidence
Reported obligations decreased 100.0% from $3.8M to $0. The office’s share of positive obligations moved from 4.5% to 0%, a change of −4.5 percentage points.
The latest period contains 0 actions across 0 awards. The preceding period contained 2 active prime contractors and 2 awards.
Contract types, competition, and procurement methods
From Oct 24, 2025 through Oct 23, 2026, 6,582 awards had positive obligations totaling $53.6M. Only One Source was the leading reported procedure, accounting for 68.8% of positive obligations. Awards with a reported parent IDV accounted for 81.5%. Reported awards used contract vehicles such as VA FSS Schedule 65IB.
- Leading award type
- 78.3%
- Delivery Order
- Leading reported procedure
- 68.8%
- Only One Source
- Reported parent IDV
- 81.5%
- of positive obligations had a reported parent IDV
- Median reported offers
- 2
- 859 of 6,582 awards reported offers · Limited reporting
Observed contract vehicles
Only exact reported parent-PIID matches are shown; missing parent IDs are not inferred.
- VA FSS Schedule 65IB
$22K
0.040% of positive obligations · 1 matched award
Same-NAICS comparison
Compared with the NAICS 325412 peer median, parent-IDV obligation share is 16.9 percentage points lower, reported full-and-open obligation share is 35.2 percentage points lower, delivery-order obligation share is 20.0 percentage points lower, and median positive award obligations are 99.9% lower.
| Measure | This market | Peer median | Difference |
|---|---|---|---|
| Parent-IDV obligation share | 81.5% | 98.4% | -16.9 pts |
| Reported full-and-open obligation share | 5.8% | 41.0% | -35.2 pts |
| Delivery-order obligation share | 78.3% | 98.3% | -20.0 pts |
| Median positive award obligations | $51 | $54K | -99.9% |
Peer cohort and comparison limits
The peer median gives each of the 3 eligible agency markets equal weight. The included agency markets are:
- Department of Health and Human Services (HHS)
- Department of Justice (DOJ)
- Department of Veterans Affairs (VA)
Agency mission, scale, and acquisition context can differ. Peer position does not establish market attractiveness or predict a future procurement method.
View buying-method details and data coverage
Award types
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Delivery Order(C) | 5,732 | $41.9M | 78.3% |
| Purchase Order(B) | 825 | $8.9M | 16.6% |
| BPA Call(A) | 22 | $1.7M | 3.3% |
| Definitive Contract(D) | 3 | $1.0M | 1.9% |
Reported parent-award types
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| IDC(B) | 5,722 | $41.0M | 76.5% |
| BPA(E) | 22 | $1.7M | 3.3% |
| FSS(C) | 10 | $961K | 1.8% |
| Not reported | 828 | $9.9M | 18.5% |
Single- or multiple-award parent structure
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Single Award(S) | 5,744 | $42.7M | 79.7% |
| Multiple Award(M) | 10 | $961K | 1.8% |
| Not reported | 828 | $9.9M | 18.5% |
Solicitation procedures
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Only One Source(SSS) | 129 | $36.9M | 68.8% |
| Simplified Acquisition(SP1) | 772 | $10.4M | 19.4% |
| Negotiated Proposal/Quote(NP) | 5,492 | $2.1M | 3.8% |
| Sss(ONLY ONE SOURCE) | 6 | $2.0M | 3.8% |
| Subject to Multiple Award Fair Opportunity(MAFO) | 11 | $1.2M | 2.3% |
| Np(NEGOTIATED PROPOSAL/QUOTE) | 71 | $828K | 1.6% |
| Other reported values | 101 | $160K | 0.30% |
Extent competed
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Not Competed(C) | 30 | $27.4M | 51.1% |
| Not Available for Competition(B) | 99 | $9.5M | 17.7% |
| Not Competed Under SAP(G) | 65 | $5.6M | 10.5% |
| Competed Under SAP(F) | 707 | $4.8M | 9.0% |
| Full and Open Competition(A) | 5,502 | $3.1M | 5.8% |
| B(NOT AVAILABLE FOR COMPETITION) | 4 | $1.8M | 3.4% |
| Other reported values | 175 | $1.3M | 2.5% |
Fair-opportunity and limited-source reporting
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Only One Source - Other(ONE) | 6 | $749K | 1.4% |
| Other Statutory Authority(OSA) | 1 | $245K | 0.46% |
| Fair Opportunity Given(FAIR) | 2 | $180K | 0.34% |
| FAR 16.505(B)(2)(I)(G) Single Source(SSRC) | 1 | $20K | 0.040% |
| FAR 16.505(B)(2)(I)(G) Limited Sources(LSRC) | 1 | $15K | 0.030% |
| Not reported | 6,571 | $52.4M | 97.7% |
Other-than-full-and-open reasons
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Only One Source-Other (FAR 6.302-1 Other)(ONE) | 133 | $38.5M | 72.0% |
| SAP Non-Competition (FAR 13)(SP2) | 71 | $5.4M | 10.1% |
| Authorized by Statute (FAR 6.302-5(A)(2)(I))(OTH) | 1 | $182K | 0.34% |
| Unique Source (FAR 6.302-1(B)(1))(UNQ) | 1 | $177K | 0.33% |
| Urgency (FAR 6.302-2)(URG) | 1 | $168K | 0.31% |
| Not reported | 6,375 | $9.1M | 16.9% |
Contract pricing types
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Firm Fixed Price(J) | 6,404 | $50.5M | 94.4% |
| J(FIRM FIXED PRICE) | 178 | $3.0M | 5.6% |
Product or Service Codes
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Drugs and Biologicals(6505) | 6,324 | $48.7M | 90.9% |
| Medical and Surgical Instruments, Equipment, and Supplies(6515) | 58 | $1.6M | 3.1% |
| Laboratory Equipment and Supplies(6640) | 6 | $1.2M | 2.3% |
| in Vitro Diagnostic Substances, Reagents, Test Kits and Sets(6550) | 50 | $761K | 1.4% |
| Pharmacy Services(Q517) | 6 | $381K | 0.71% |
| Medical- Radiology(Q522) | 1 | $262K | 0.49% |
| Other reported values | 137 | $608K | 1.1% |
Awarding subagencies
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Defense Logistics Agency(97AS) | 6,480 | $36.4M | 68.0% |
| Department of the Army(2100) | 56 | $11.6M | 21.6% |
| Defense Health Agency(97DH) | 45 | $5.5M | 10.4% |
| U.S. Special Operations Command(97ZS) | 1 | $7K | 0.010% |
Awarding offices
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Dla Troop Support(SPE2DP) | 738 | $23.5M | 43.8% |
| Dla Troop Support(SPE2D6) | 103 | $11.3M | 21.2% |
| W40m Mrc0 West(W81K00) | 37 | $9.4M | 17.5% |
| Defense Health Agency(HT0014) | 12 | $2.3M | 4.2% |
| Defense Health Agency Hcd West(HT9410) | 12 | $1.8M | 3.4% |
| W40m Usa Hca(W81K04) | 12 | $1.5M | 2.9% |
| Other reported values | 5,668 | $3.8M | 7.0% |
Reported parent IDVs
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| SPE2DP20D0002(9700) | 21 | $21.9M | 40.9% |
| SPE2DP23D0001(9700) | 103 | $11.3M | 21.2% |
| W81K0024D0004(9700) | 1 | $3.2M | 6.0% |
| SPE2DP21D0002(9700) | 3 | $1.2M | 2.2% |
| SPE2DX25D8022(9700) | 4,651 | $925K | 1.7% |
| HT940625DE001(9700) | 1 | $401K | 0.75% |
| V797D60737(3600) | 5 | $384K | 0.72% |
| HT001424A0002(9700) | 5 | $344K | 0.64% |
| Other reported values | 964 | $3.9M | 7.3% |
| Not reported | 828 | $9.9M | 18.5% |
Exact vehicle-match evidence
$22K · 0.040%
Reported award data linked 1 award to a specific catalog vehicle.
Offers, award size, and timing
- Median reported offers
- 2 median
- 859 reported · 5,723 not reported · Limited reporting
- Positive award obligations
- $51 median
- $16–$185 middle 50%
- Reported performance period
- 0 days median
- 6,582 reported · 0 not reported
- Zero days means the reported start and current-end dates were the same.
Calculations group latest-period actions by award, retain awards with positive net obligations for share denominators, and use each award's latest reported USAspending procurement fields as of Oct 23, 2026. Blank competition, pricing, PSC, or parent-IDV values remain not reported; they are not inferred. Offer counts must be positive and below the FPDS 999 placeholder. Awarding organizations can differ from the funding agency that defines this page.
Top federal contractors
Latest 12-month market share, concentration, and complete prime contractor rankings across the period shown.
- Prime contractor concentration
- 6 of 72prime contractors account for at least 80% of positive obligations in the last 12 months
- Largest prime contractor
- 41.3%of positive obligations in the last 12 months
- Leading four prime contractors
- 76.9%of positive obligations in the last 12 months
- Leading eight prime contractors
- 84.5%of positive obligations in the last 12 months
Based on $53.1M in positive obligations during the 12 months ending Oct 23, 2026. Individual shares and movement appear in the searchable rankings below. Movement compares with Oct 24, 2024–Oct 23, 2025.
Last 12mo obligation volume: Highest positive obligations first; net deobligations follow by magnitude; contractors with no activity in the last 12 months follow by all-period obligations. Ranks use the complete contractor list and remain fixed when search narrows the results.
- #1
Last 12mo obligations
$21.9M
41.3%
Dollar movement
−$18.3M
vs. prior 12 months
Last 12mo awards
21 awards
21 actions
Historical and award details for TEVA PHARMACEUTICALS USA, INC.
- Obligations: prior → latest
- $40.2M → $21.9M
- −45.4%
- Share: prior → latest
- 48.0% → 41.3%
- −6.7 percentage points
- All-period obligations
- $172.4M
- 0.66% of all-period positive obligations · 332 awards
- Recorded activity
- Since Nov 9, 2021
- through Apr 15, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 1 Not reported 21 66 Reported small business 0 0 All-period set-aside types
None reported.
- #2
Last 12mo obligations
$12.4M
23.3%
Dollar movement
+$324K
vs. prior 12 months
Last 12mo awards
107 awards
107 actions
Historical and award details for CANADIAN COMMERCIAL CORPORATION
- Obligations: prior → latest
- $12.0M → $12.4M
- +2.7%
- Share: prior → latest
- 14.4% → 23.3%
- +8.9 percentage points
- All-period obligations
- $112.7M
- 0.43% of all-period positive obligations · 1,040 awards
- Recorded activity
- Since Oct 6, 2021
- through Jul 20, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 107 201 Reported small business 0 0 All-period set-aside types
None reported.
- #3
Last 12mo obligations
$4.3M
8.1%
Dollar movement
+$3.9M
vs. prior 12 months
Last 12mo awards
4 awards
6 actions
Historical and award details for NOVARTIS PHARMACEUTICALS CORPORATION
- Obligations: prior → latest
- $426K → $4.3M
- +907.5%
- Share: prior → latest
- 0.51% → 8.1%
- +7.6 percentage points
- All-period obligations
- $4.7M
- 0.020% of all-period positive obligations · 6 awards
- Recorded activity
- Since Jul 1, 2025
- through Feb 11, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 2 1 Not reported 2 2 Reported small business 0 0 All-period set-aside types
None reported.
- #4
Last 12mo obligations
$2.2M
4.2%
Dollar movement
−$722K
vs. prior 12 months
Last 12mo awards
16 awards
21 actions
Historical and award details for CARDINAL HEALTH 414, LLC
- Obligations: prior → latest
- $3.0M → $2.2M
- −24.4%
- Share: prior → latest
- 3.5% → 4.2%
- +0.7 percentage points
- All-period obligations
- $14.5M
- 0.060% of all-period positive obligations · 77 awards
- Recorded activity
- Since Oct 6, 2021
- through Apr 20, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 12 16 Not reported 4 5 Reported small business 0 0 All-period set-aside types
None reported.
- #5
Last 12mo obligations
$1.2M
2.2%
Dollar movement
+$108K
vs. prior 12 months
Last 12mo awards
1 award
2 actions
Historical and award details for JUBILANT HOLLISTERSTIER LLC
- Obligations: prior → latest
- $1.0M → $1.2M
- +10.3%
- Share: prior → latest
- 1.3% → 2.2%
- +0.9 percentage points
- All-period obligations
- $3.1M
- 0.010% of all-period positive obligations · 1 award
- Recorded activity
- Since Sep 29, 2023
- through Apr 9, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 1 1 Not reported 0 0 Reported small business 0 0 All-period set-aside types
None reported.
- #6
Last 12mo obligations
$1.1M
2.0%
Dollar movement
+$437K
vs. prior 12 months
Last 12mo awards
5 awards
11 actions
Historical and award details for LANTHEUS MEDICAL IMAGING, INC.
- Obligations: prior → latest
- $625K → $1.1M
- +69.9%
- Share: prior → latest
- 0.75% → 2.0%
- +1.3 percentage points
- All-period obligations
- $4.3M
- 0.020% of all-period positive obligations · 32 awards
- Recorded activity
- Since Oct 7, 2021
- through Apr 16, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 1 2 Reported no set-aside 2 4 Not reported 2 1 Reported small business 4 4 All-period set-aside types
- 3 · Total small business
- #7
Last 12mo obligations
$925K
1.7%
Dollar movement
−$525K
vs. prior 12 months
Last 12mo awards
4,986 awards
4,986 actions
Historical and award details for CARDINAL HEALTH, INC.
- Obligations: prior → latest
- $1.5M → $925K
- −36.2%
- Share: prior → latest
- 1.7% → 1.7%
- 0.0 percentage points
- All-period obligations
- $7.5M
- 0.030% of all-period positive obligations · 24,665 awards
- Recorded activity
- Since Oct 1, 2021
- through Jul 20, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 4,986 4,635 Reported small business 0 0 All-period set-aside types
None reported.
- #8
Last 12mo obligations
$883K
1.7%
Dollar movement
+$451K
vs. prior 12 months
Last 12mo awards
2 awards
3 actions
Historical and award details for BRACCO DIAGNOSTICS INC.
- Obligations: prior → latest
- $432K → $883K
- +104.2%
- Share: prior → latest
- 0.52% → 1.7%
- +1.1 percentage points
- All-period obligations
- $1.7M
- 0.010% of all-period positive obligations · 6 awards
- Recorded activity
- Since Dec 15, 2021
- through Dec 15, 2025
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 2 3 Not reported 0 0 Reported small business 0 0 All-period set-aside types
None reported.
- #9
Last 12mo obligations
$757K
1.4%
Dollar movement
−$119K
vs. prior 12 months
Last 12mo awards
4 awards
8 actions
Historical and award details for PETNET SOLUTIONS, INC.
- Obligations: prior → latest
- $876K → $757K
- −13.6%
- Share: prior → latest
- 1.1% → 1.4%
- +0.4 percentage points
- All-period obligations
- $3.2M
- 0.010% of all-period positive obligations · 26 awards
- Recorded activity
- Since Oct 1, 2021
- through Apr 3, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 4 11 Not reported 0 0 Reported small business 0 0 All-period set-aside types
None reported.
- #10
Last 12mo obligations
$704K
1.3%
Dollar movement
−$638K
vs. prior 12 months
Last 12mo awards
4 awards
10 actions
Historical and award details for BOSTON SCIENTIFIC CORP
- Obligations: prior → latest
- $1.3M → $704K
- −47.5%
- Share: prior → latest
- 1.6% → 1.3%
- −0.3 percentage points
- All-period obligations
- $4.0M
- 0.020% of all-period positive obligations · 19 awards
- Recorded activity
- Since Oct 27, 2021
- through Apr 8, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 2 4 Not reported 2 2 Reported small business 0 0 All-period set-aside types
None reported.
- #11
Last 12mo obligations
$593K
1.1%
Dollar movement
+$972K
vs. prior 12 months
Last 12mo awards
1 award
3 actions
Historical and award details for HAMAMATSU/QUEEN'S PET IMAGING CENTER, LLC
- Obligations: prior → latest
- −$379K → $593K
- Not comparable
- Share: prior → latest
- 0% → 1.1%
- +1.1 percentage points
- All-period obligations
- $981K
- 0% of all-period positive obligations · 1 award
- Recorded activity
- Since Sep 23, 2024
- through Apr 2, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 1 1 Not reported 0 0 Reported small business 1 1 All-period set-aside types
None reported.
- #12
Last 12mo obligations
$532K
1.0%
Dollar movement
−$626K
vs. prior 12 months
Last 12mo awards
6 awards
7 actions
Historical and award details for SOFIE CO.
- Obligations: prior → latest
- $1.2M → $532K
- −54.1%
- Share: prior → latest
- 1.4% → 1.0%
- −0.4 percentage points
- All-period obligations
- $4.3M
- 0.020% of all-period positive obligations · 57 awards
- Recorded activity
- Since Oct 1, 2021
- through Feb 4, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 6 13 Not reported 0 0 Reported small business 0 1 All-period set-aside types
None reported.
- #13
Last 12mo obligations
$531K
1.0%
Dollar movement
+$531K
vs. prior 12 months
Last 12mo awards
3 awards
6 actions
Historical and award details for AMERICAN NATIONAL SERVICES LLC
- Obligations: prior → latest
- $0 → $531K
- Not comparable
- Share: prior → latest
- 0% → 1.0%
- +1.0 percentage points
- All-period obligations
- $2.5M
- 0.010% of all-period positive obligations · 9 awards
- Recorded activity
- Since Nov 5, 2021
- through Apr 6, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 2 1 Reported no set-aside 0 0 Not reported 1 1 Reported small business 3 2 All-period set-aside types
- 2 · Total small business
- #14
Last 12mo obligations
$496K
0.93%
Dollar movement
−$105K
vs. prior 12 months
Last 12mo awards
8 awards
20 actions
Historical and award details for INO THERAPEUTICS LLC
- Obligations: prior → latest
- $601K → $496K
- −17.5%
- Share: prior → latest
- 0.72% → 0.93%
- +0.2 percentage points
- All-period obligations
- $3.4M
- 0.010% of all-period positive obligations · 23 awards
- Recorded activity
- Since Oct 18, 2021
- through Apr 15, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 2 2 Not reported 6 7 Reported small business 0 0 All-period set-aside types
None reported.
- #15
Last 12mo obligations
$431K
0.81%
Dollar movement
−$189K
vs. prior 12 months
Last 12mo awards
1 award
1 action
Historical and award details for CEPHEID
- Obligations: prior → latest
- $620K → $431K
- −30.4%
- Share: prior → latest
- 0.74% → 0.81%
- +0.1 percentage points
- All-period obligations
- $2.6M
- 0.010% of all-period positive obligations · 1 award
- Recorded activity
- Since Oct 8, 2021
- through Dec 22, 2025
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 1 1 Not reported 0 0 Reported small business 0 0 All-period set-aside types
None reported.
Recent federal contract award activity
Recent contract actions with unusually large obligation changes or meaningful shifts in contractor and funding-office activity.
This action
+$3.2M
NOVARTIS PHARMACEUTICALS CORPORATION
AMC BAMC FSH - MM
LUTATHERA AND PLUVICTO - FY26 FUNDING FOR CLINS 0001 AND 0002 FOR POP DATE FROM 1OCT25 TO 30 SEPT 26.
Why it stands out
The contractor climbed 20 positions in this market.
It now ranks #3 by positive obligations over the latest 12 months.
- Award net obligations
- $3.2M
- Share of 12-month positive obligations
- 6.0%
Supporting data
- Prime contractor
- #3 · 8.1% share
- up 20 ranks · +7.6 percentage points · $3.9M net increase; action accounted for 82.1%
- Funding office
- #3 · 11.1% attributed share
- up 2 ranks · +7.5 percentage points · $2.9M net increase; action exceeded it by $279K
This action
+$5.2M
CANADIAN COMMERCIAL CORPORATION
DLA TROOP SUPPORT
4571290114!REACTIVE SKIN DECONTAMINATION LOTION
Why it stands out
One action represented 9.8% of the market’s latest 12-month positive obligations.
At $5.2M, the action was large enough to materially affect the latest 12-month market picture.
- Award net obligations
- $5.2M
- Share of 12-month positive obligations
- 9.8%
Supporting data
- Funding office
- #2 · 21.4% attributed share
- $188K net decline despite this positive action
This action
+$4.0M
TEVA PHARMACEUTICALS USA, INC.
DLA TROOP SUPPORT
8511984334!ADENOVIRUS TYPE 4 A
Why it stands out
A new award added obligations despite weaker contractor activity.
The action represented 7.4% of the market’s latest 12-month positive obligations while the contractor’s obligations fell $18.3M overall.
- Award net obligations
- $4.0M
- Share of 12-month positive obligations
- 7.4%
Supporting data
- Prime contractor
- #1 · 41.3% share
- $18.3M net decline despite this positive action
- Funding office
- #1 · 43.2% attributed share
- $24.2M net decline despite this positive action
This action
+$593K
HAMAMATSU/QUEEN'S PET IMAGING CENTER, LLC
AMC TRIPLER SHAFTER - MM
FDG-18 FOR TAMC, HAWAII.
Why it stands out
The award grew alongside stronger contractor activity.
The modification added $593K while contractor obligations rose $972K overall.
- Award net obligations
- $981K
- Share of 12-month positive obligations
- 1.1%
Supporting data
- Prime contractor
- #11 · 1.1% share
- +1.1 percentage points · $972K net increase; action accounted for 61.0%
- Funding office
- #7 · 2.0% attributed share
- +2.0 percentage points · $1.3M net increase; action accounted for 46.2%
This action
+$864K
JUBILANT HOLLISTERSTIER LLC
KIMBROUGH AMB CC MEADE - MM
ANTIVENOM IMMUNOTHERAPY SUPPLIES
Why it stands out
This award grew while spending attributed to its office declined.
The modification added $864K while office-attributed obligations fell $513K overall.
- Award net obligations
- $3.1M
- Share of 12-month positive obligations
- 1.6%
Supporting data
- Funding office
- #6 · 2.2% attributed share
- $513K net decline despite this positive action
This action
+$553K
BOSTON SCIENTIFIC CORP
AMC BAMC FSH - MM
TRANSARTERIAL RADIOEMBOLIZATION USING YTTRIUM-90 MICROSPHERES IS A THERAPEUTIC OPTION FOR PATIENTS WITH INTERMEDIATE-OR ADVANCED-STAGE HEPATOCELLULAR CARCINOMA, INCLUDING THOSE WITH RECURRENT OR INOPERABLE HEPATOCELLULAR CARCINOMA.
Why it stands out
The funding office climbed 2 positions in attributed spending.
It now ranks #3 in attributed spending.
- Award net obligations
- $553K
- Share of 12-month positive obligations
- 1.0%
Supporting data
- Prime contractor
- #10 · 1.3% share
- $638K net decline despite this positive action
View recent award activity by date (10)
- Action+$304Award net obligations$304
- Action+$243Award net obligations$243
- Action+$2KAward net obligations$2K
- Action+$2KAward net obligations$2K
- Action+$17Award net obligations$17
- Action+$17Award net obligations$17
- Action+$180Award net obligations$180
- Action+$6KAward net obligations$6K
- Action+$53Award net obligations$53
- Action+$25Award net obligations$25
DoD pharmaceutical preparation manufacturing market FAQs
Answers based on reported federal contract data.
Who are the top DoD pharmaceutical preparation manufacturing contractors?
In the 12 months through October 23, 2026, TEVA PHARMACEUTICALS USA, INC., CANADIAN COMMERCIAL CORPORATION, and NOVARTIS PHARMACEUTICALS CORPORATION were the leading DoD pharmaceutical preparation manufacturing prime contractors by positive obligations.
- #1
TEVA PHARMACEUTICALS USA, INC.
$21,926,233 in positive obligations
- #2
CANADIAN COMMERCIAL CORPORATION
$12,359,869 in positive obligations
- #3
NOVARTIS PHARMACEUTICALS CORPORATION
$4,292,412 in positive obligations
Rankings use reported USAspending award data.
Did DoD contract obligations decrease in the pharmaceutical preparation manufacturing market?
Yes. Measured by net prime contract obligations, reported DoD activity in the pharmaceutical preparation manufacturing market decreased 36.2% from $83,029,440 in the preceding 12 months to $52,933,038 in the 12 months through October 23, 2026.
- Latest 12 months
- $52,933,038
- Net prime contract obligations
- Preceding 12 months
- $83,029,440
- Net prime contract obligations
- Change
- −36.2%
- Between matched 12-month periods
Reported contract actions, not outlays or a forecast.
What recent DoD contract award activity was reported in the pharmaceutical preparation manufacturing market?
Recent DoD contract award activity reported in the pharmaceutical preparation manufacturing market included actions for NOVARTIS PHARMACEUTICALS CORPORATION, CANADIAN COMMERCIAL CORPORATION, and TEVA PHARMACEUTICALS USA, INC. during the 12 months through October 23, 2026.
-
NOVARTIS PHARMACEUTICALS CORPORATION · PIID W81K0025FA195
Modification P00002 · December 8, 2025 · Action obligation: +$3,175,976
-
CANADIAN COMMERCIAL CORPORATION · PIID SPE2D626F6F83
Base award · March 26, 2026 · Action obligation: +$5,197,198
-
TEVA PHARMACEUTICALS USA, INC. · PIID SPE2DP26F3586
Base award · March 18, 2026 · Action obligation: +$3,950,554
-
HAMAMATSU/QUEEN'S PET IMAGING CENTER, LLC · PIID W81K0224P0077
Modification P00005 · December 17, 2025 · Action obligation: +$592,597
-
JUBILANT HOLLISTERSTIER LLC · PIID W91YTZ23P0137
Modification P00008 · April 9, 2026 · Action obligation: +$864,434
-
BOSTON SCIENTIFIC CORP · PIID W81K0025PA252
Modification P00002 · December 22, 2025 · Action obligation: +$552,770
Action obligations are transaction-level amounts, not current award-level obligations.
Which procurement methods were reported for DoD contracts under NAICS 325412?
From October 24, 2025 through October 23, 2026, DoD reported 6,582 positive-obligation awards for pharmaceutical preparation manufacturing under NAICS 325412. The leading award type was delivery order. The leading reported procedure was only one source.
- Positive-obligation awards
- 6,582
- Leading reported procedure
- Only One Source
- 68.8% of positive obligations
- Leading award type
- Delivery Order
- 78.3% of positive obligations
- Full and open
- 5.8%
- of positive obligations
- Reported parent IDV
- 81.5%
- of positive obligations
Percentages use positive obligations as the denominator.
Apply this research to a live pursuit
Sweetspot connects opportunity qualification, competitive research, capture, and proposal work in one workspace.
Related market research
Complete market indexes:
Same NAICS at other agencies:
Nearby NAICS at this agency:
Markets sharing leading prime records:
Leading-prime vehicle memberships:
Company memberships do not establish award-channel use.Reported obligations include contract actions from October 1, 2021 through October 23, 2026. Set-aside and business-size fields reflect award records, not a contractor's current eligibility. Public Department of Defense award records are generally delayed by 90 days.
Review data methodology